Skip to content

Clinical trials

Phase 3 Insulin Resistance trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 3 Country / region: Mexico Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20082
20131
20141
20161
20193
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Central "Dr. Ignacio Morones Prieto"2
Universidad de Guanajuato2
AstraZeneca1
Centro Universitario de Ciencias de la Salud, Mexico1
Coordinación de Investigación en Salud, Mexico1
Eli Lilly and Company1
Instituto Nacional de Salud Publica, Mexico1
Instituto de Oftalmología Fundación Conde de Valenciana1
Sanofi1
Unidad de Investigacion Medica en Epidemiologia Clinica1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance12
Diabetes Mellitus3
Diabetes Mellitus, Type 23
Prediabetic State3
Dry Eye Syndromes1
Fibrosis1
Glucose Intolerance1
Hyperglycemia1
Metabolic Diseases1
Metabolic Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.